Elevated serum level of interleukin-10 in patients with systemic sclerosis.

Suppr

超能文献

作者信息

Kucharz E J, Brzezinska-Wcislo L, Kotulska A, Gasiorowska-Kielkowska W, Gozdzik J

出版信息

Clin Rheumatol. 1997 Nov;16(6):638-9. doi: 10.1007/BF02247812.

DOI:10.1007/BF02247812

PMID:9456024

Abstract

摘要

相似文献

Elevated serum level of interleukin-10 in patients with systemic sclerosis.

Clin Rheumatol. 1997 Nov;16(6):638-9. doi: 10.1007/BF02247812.

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.

J Rheumatol. 1997 Feb;24(2):328-32.

Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.

J Rheumatol. 2006 Feb;33(2):275-84.

Duration of Raynaud's phenomenon is negatively correlated with serum levels of interleukin 10 (IL-10), soluble receptor of interleukin 2 (sIL2R), and sFas in systemic sclerosis patients.

Med Sci Monit. 2004 May;10(5):CR202-8. Epub 2004 Apr 28.

Regulatory T-cell detection by flow cytometry and systemic sclerosis.

Clin Transl Sci. 2011 Feb;4(1):72. doi: 10.1111/j.1752-8062.2011.00265.x.

Serum interleukin-6 level in patients with systemic sclerosis: lack of correlation with aminoterminal propeptide of type III procollagen.

Clin Rheumatol. 1995 May;14(3):380-1. doi: 10.1007/BF02208360.

Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis.

Ann Rheum Dis. 1991 Apr;50(4):270-1. doi: 10.1136/ard.50.4.270-b.

Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma.

Arch Dermatol Res. 1995;287(2):193-7. doi: 10.1007/BF01262331.

Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis.

J Dermatol. 2010 Sep;37(9):801-6. doi: 10.1111/j.1346-8138.2010.00883.x.

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.

J Rheumatol. 1990 Jul;17(7):908-10.

引用本文的文献

Upcoming treatments for morphea.

Immun Inflamm Dis. 2021 Dec;9(4):1101-1145. doi: 10.1002/iid3.475. Epub 2021 Jul 17.

Immune Components of Liver Damage Associated with Connective Tissue Diseases.

J Clin Transl Hepatol. 2014 Mar;2(1):37-44. doi: 10.14218/JCTH.2014.00001. Epub 2014 Mar 15.

Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.

Clin Exp Immunol. 2013 Aug;173(2):195-206. doi: 10.1111/cei.12111.

Dendritic cells: novel players in fibrosis and scleroderma.

Curr Rheumatol Rep. 2012 Feb;14(1):30-8. doi: 10.1007/s11926-011-0215-5.

本文引用的文献

Interleukin-10.

Annu Rev Immunol. 1993;11:165-90. doi: 10.1146/annurev.iy.11.040193.001121.

[Classification of progressive systemic scleroderma].

Hautarzt. 1987 May;38(5):253-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验